Nevirapine D4

Stability-indicating UHPLC method for determination of nevirapine in its bulk form and tablets: identification of impurities and degradation kinetic study
Naialy Fernandes AraújoReisaJéssica Camillede AssisaSílvia LigórioFialhobGerson AntônioPianettiaChristianFernandes
Journal of Pharmaceutical and Biomedical Analysis Volume 126, 15 July 2016, Pages 103-108
 
High Resolution Rp-Hplc Method for The Determination of Nevirapine and Associated Impurities.
R. S. Ch. Phani.*, K. R. S. Prasad and Useni Reddy Mallu
Oriental journal of chemistry 2016, Vol. 32, No. (2): Pg. 1193-1203
 
Process Design and Optimization for the Continuous Manufacturing of Nevirapine, an Active Pharmaceutical Ingredient for HIV Treatment
Samir Diab, D. Tyler McQuade, B. Frank Gupton, and Dimitrios I. Gerogiorgis
Org. Process Res. Dev. 2019, 23, 3, 320–333
 
Spectrophotometric determination of nevirapine using tetrathiocyanatocobalt(II) ion as a reagent
T. V. Sreevidya; B. Narayana
Eclet. Quím. vol.35 no.3 São Paulo Sept. 2010
 
Identification, Isolation and Characterization of Unknown Acid Degradation Product of Nevirapine
Vasudev Pottabathini1, Vijayacharan Gugulothu1, Muralidharan Kaliyaperumal2, Satyanarayana Battu1
American Journal of Analytical Chemistry, 2016, Vol-7, 663-678
 

Nevirapine D4 is chemically 11-(Cyclopropyl-2,2,3,3-d4)-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one. Nevirapine D4 is supplied with detailed characterization data compliant with regulatory guideline. Nevirapine D4 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nevirapine .

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.